Patents by Inventor Georg-Fredinand Sclingensiepen

Georg-Fredinand Sclingensiepen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta)
    Publication number: 20030040499
    Abstract: Antisense-oligonucleotides or effective derivatives thereof hybridizing with an area of a gene coding for transforming growth factor-&bgr; (TGF-&bgr;) comprising the following nucleic acid sequences identified in the sequence listing under SEQ ID NO. 1-56 and 137 or comprising the following nucleic acid sequences identified in the sequence listing under SEQ ID NO. 57 to 136 each of the nucleic acids having a DNA- or RNA-type structure.
    Type: Application
    Filed: May 16, 2002
    Publication date: February 27, 2003
    Applicant: Biognostik Gesellschaft Fur Biomolekulare Diagnostik mbH
    Inventors: Georg-Fredinand Sclingensiepen, Wolfgang Brysch, Karl-Hermann Schlingensiepen, Reimar Schlingensiepen, Ulrich Bogdahn